Company registration number 08264954 (England and Wales)
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
COMPANY INFORMATION
Directors
P. S. Patel
A. P. Patel
S. C. Patel
S. P. Foxon
T. D. Teubner
Company number
08264954
Registered office
Unit 3 Devonshire Business Park
Chester Road
Borehamwood
Hertfordshire
WD6 1NA
Auditor
TC Group
5th Floor
3 Dorset Rise
London
EC4Y 8EN
Business address
Unit 3 Devonshire Business Park
Chester Road
Borehamwood
Hertfordshire
WD6 1NA
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3
Directors' responsibilities statement
4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 20
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
The directors present the strategic report for the year ended 31 December 2024.
Review of the business
The results of the year and the financial position at the year end were considered satisfactory by the directors. The company operated one nursing home which is located in Redbridge and provides 60 registered beds.
Turnover has increased from the previous year due to the increase in the average weekly bed fees and occupied beds.
The directors are proud of the uninterrupted and high-quality care service that they were able to continuously deliver in the company's care home throughout the year. The company has continued to achieve high standards as indicated by the CQC reports with the care home achieving a 'good' rating.
The care home continues to perform very well with good relationships with local authorities, NHS and the community.
Principal Risks and Uncertainties
The company operates in a competitive and highly regulated environment, facing the same sector-wide challenges as other providers of residential and nursing care.
We remain committed to delivering safe, secure, and high-quality care in a homely environment, guided by our values of compassion and respect. As Government regulations continue to evolve, we adapt our operational practices to maintain compliance at all times, ensuring that we remain credible in the eyes of regulators, residents, and families.
Description of Principal Risks and Uncertainties
Reputational Risk
The quality of care we provide is central to our reputation. Any failure to maintain high standards would damage both the brand and our ability to attract new residents. To mitigate this, robust performance monitoring systems are in place, with regular oversight from senior management and the Board.
Health and Safety
The wellbeing of residents, staff, and visitors is of paramount importance. We believe that no serious injury is acceptable. Everyone in the home is accountable for maintaining safety and is supported with training, equipment, and resources. Oversight is provided by a dedicated health and safety team, ensuring a collaborative approach to safety.
Employment of Staff
The skills and expertise of our staff are critical to the delivery of outstanding care. Like the wider sector, we face challenges from a national shortage of qualified nursing staff. To address this, our proactive Human Resources and Recruitment team continues to source talent both domestically and internationally, while also focusing on retention and staff wellbeing.
Future Developments and Performance
The company’s primary strategy is to maintain the high standards of care within its care home while supporting the wider Westgate Healthcare Group in delivering sustainable growth.
As Government and Local Authority funding pressures persist, reducing fees for publicly funded residents, the company continues to strengthen its offer for privately funded individuals. This approach ensures the long-term resilience of the business while upholding the values of being compassionate, committed, collaborative, and credible in everything we do.
- 1 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
Key performance indicators
The key performance indicators used by the directors to assess the performance of the company are as follows:
| | | | |
| | | | |
| | | | |
Turnover Operating profit Average occupancy rates | | | | |
S. C. Patel
Director
25 September 2025
- 2 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
The directors present their annual report and financial statements for the year ended 31 December 2024.
Principal activities
The principal activity of the company is that of owning and running residential care and nursing homes.
Results and dividends
The results for the year are set out on page 8.
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
P. S. Patel
A. P. Patel
S. C. Patel
S. P. Foxon
T. D. Teubner
Future developments
Details of future developments are provided in the Strategic Report.
Auditor
The auditor, TC Group, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
S. C. Patel
Director
25 September 2025
- 3 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
State whether the financial statements have been prepared in accordance with applicable accounting standards, identify those standards, and note the effect and the reasons for any material departure from those standards; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
- 4 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF WESTGATE HEALTHCARE (WANSTEAD) LIMITED
Opinion
- 5 -
We have audited the financial statements of Westgate Healthcare (Wanstead) Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WESTGATE HEALTHCARE (WANSTEAD) LIMITED
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
- 6 -
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Extent to which the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect irregularities, including fraud. The risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below. However, the primary responsibility for the prevention and detection of fraud rests with both those charged with governance of the entity and management.
Our approach was as follows:
We obtained an understanding of the legal and regulatory frameworks that are applicable to the company and determined that the most significant are those that relate to the reporting framework (FRS 102, the Companies Act 2006), those required by the Care Quality Commission and the relevant direct and indirect tax compliance regulations in the United Kingdom.
We understood how the company is complying with those frameworks by making enquiries of management and seeking representations from those charged with governance. We corroborated our understanding by reviewing supporting documentation.
Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Our procedures involved enquiries of management and those charged with governance and review of legal and professional expenses.
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WESTGATE HEALTHCARE (WANSTEAD) LIMITED
We assessed the susceptibility of the company’s financial statements to material misstatement, including how fraud might occur by considering the risk of management override of internal control and by designating revenue recognition as a fraud risk. We performed journal entry testing by specific risk criteria, with a focus on journals indicating large or unusual transactions based on our understanding of the business. We tested completeness of income through substantive tests performed, analytical review procedures and cut off tests on the revenue recognised.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Stephen Simou FCA
Senior Statutory Auditor
For and on behalf of TC Group
30 September 2025
Statutory Auditor
5th Floor
3 Dorset Rise
London
EC4Y 8EN
- 7 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
2024
2023
Notes
£
£
Turnover
3
4,322,455
2,683,310
Administrative expenses
(3,090,629)
(2,649,737)
Other operating income
21,759
21,973
Operating profit
4
1,253,585
55,546
Interest payable and similar expenses
6
(518,797)
(497,111)
Profit/(loss) before taxation
734,788
(441,565)
Tax on profit/(loss)
7
(170,000)
(195,000)
Profit/(loss) for the financial year
564,788
(636,565)
Other comprehensive income
Revaluation of tangible fixed assets
4,371,770
Tax relating to other comprehensive income
(1,116,000)
Total comprehensive income for the year
564,788
2,619,205
The profit and loss account has been prepared on the basis that all operations are continuing operations.
- 8 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
8
17,247,706
17,300,000
Current assets
Debtors
9
3,112,648
3,107,213
Cash at bank and in hand
265,919
281,828
3,378,567
3,389,041
Creditors: amounts falling due within one year
10
(12,203,957)
(12,827,086)
Net current liabilities
(8,825,390)
(9,438,045)
Total assets less current liabilities
8,422,316
7,861,955
Creditors: amounts falling due after more than one year
11
(4,427)
Provisions for liabilities
Deferred tax liability
13
2,137,000
2,137,000
(2,137,000)
(2,137,000)
Net assets
6,285,316
5,720,528
Capital and reserves
Called up share capital
15
2
2
Revaluation reserve
16
5,190,892
5,190,892
Profit and loss reserves
1,094,422
529,634
Total equity
6,285,316
5,720,528
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 25 September 2025 and are signed on its behalf by:
S. C. Patel
Director
Company registration number 08264954 (England and Wales)
- 9 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
Share capital
Revaluation reserve
Profit and loss reserves
Total
£
£
£
£
Balance at 1 January 2023
2
1,935,122
1,166,199
3,101,323
Year ended 31 December 2023:
Loss
-
-
(636,565)
(636,565)
Other comprehensive income:
Revaluation of tangible fixed assets
-
4,371,770
-
4,371,770
Tax relating to other comprehensive income
-
(1,116,000)
(1,116,000)
Total comprehensive income
-
3,255,770
(636,565)
2,619,205
Balance at 31 December 2023
2
5,190,892
529,634
5,720,528
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
564,788
564,788
Balance at 31 December 2024
2
5,190,892
1,094,422
6,285,316
- 10 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
Company information
Westgate Healthcare (Wanstead) Limited is a private company limited by shares incorporated in England and Wales. The registered office and business address is at Unit 3 Devonshire Business Park, Chester Road, Borehamwood, Hertfordshire, WD6 1NA.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties at fair value. The principal accounting policies adopted are set out below.
The company has taken advantage of the following disclosure exemptions on the grounds that consolidated financial statements are prepared by the parent company, Westgate Healthcare Group Limited, copies of which are available from its registered office at Unit 3 Devonshire Business Park, Chester Road, Borehamwood, Hertfordshire, WD6 1NA:
the requirement to prepare a statement of cash flows. [Section 7 of FRS 102 and para 3.17(d)];
certain financial instrument disclosures. [FRS 102 paras 11.39 - 11.48A, 12.26 - 12.29].
the non-disclosure of key management personnel compensation in total. [FRS 102 para 33.7].
1.2
Going concern
The financial statements have been prepared on a going concern basis notwithstanding the excess of truecurrent liabilities over current assets. Because of the forbearance of the company's creditors and their willingness to support the company, the directors are confident that the company will be able continue its activities for the foreseeable future.
1.3
Turnover
Turnover represents the amounts due in exchange for services rendered and is recognised as earned when, and to the extent, that the company obtains the right to consideration in exchange for its performance. It is derived entirely from the company’s principle activities that are exempt for VAT purposes.
Turnover reflects the accrual of the right to consideration by reference to the value of the services rendered. Turnover not billed is included in debtors, and amounts received on account in excess of the relevant amount of revenue are included in creditors.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold buildings
Nil
Plant and machinery
15% reducing balance
Fixtures, fittings & equipment
15% reducing balance
- 11 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
Freehold property is held in the accounts under the revaluation model. Revaluations will be made with sufficient regularity to ensure that the carrying amount does not differ materially from that which would be determined using fair value at the end of the reporting period.
No depreciation is provided on the company’s freehold building. Given the length of life of the building and because it is maintained to a high standard, it is the opinion of the directors that the residual value would be sufficiently high to make any depreciation charge immaterial.
The land and buildings have been valued on an open value basis at 31 December 2024 by the directors but with reference to independent professional valuations undertaken in connection with the company’s financing facilities.
The surplus or deficit on book value is transferred to the revaluation reserve, except that a deficit which is in excess of any previously recognised surplus over depreciated cost relating to the same property, or the reversal of such a deficit, is charged (or credited) to the profit and loss account. A deficit which represents a clear consumption of economic benefits is charged to the profit and loss account regardless of any such previous surplus.
On disposal or recognition of a provision for impairment of a revalued fixed asset any related balance remaining in the revaluation reserve is also transferred to the profit and loss account as a movement on reserves.
1.5
Impairment of fixed assets
- 12 -
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Cash and cash equivalents
Cash and cash equivalents include cash in hand and deposits held at call with banks.
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
1.7
Financial instruments
A financial instrument is a contract that gives rise to a financial asset of one entity and a financial liability of another entity.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. The impairment loss is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including trade and other payables, bank loans and loans from fellow group companies are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
- 13 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
- 14 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
All borrowing costs, including interest incurred on loans used to finance construction projects, are recognised in the profit and loss over the term of the borrowings.
2
Judgements and key sources of estimation uncertainty
The directors make estimates and assumptions concerning the future. The resulting accounting estimate will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below.
The company carries its freehold land and property under the revaluation model. The land and buildings have been valued on an open value basis at 31 December 2024 by the directors but with reference to independent professional valuations undertaken in connection with the company’s financing facilities. The valuer used a valuation technique based on a fair maintainable trade value which is the sustainable income and costs multiplied by a factor and using assumptions of the demographic of the area and local competitors. There is a degree of estimation involved in that each property is unique and the value can only ultimately be reliably tested in the market itself.
3
Turnover and other revenue
An analysis of the company's turnover is as follows:
2024
2023
£
£
Turnover analysed by class of business
Rendering of residential care and nursing home services
4,322,455
2,683,310
2024
2023
£
£
Other revenue
Placement fees
21,759
21,973
- 15 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
4
Operating profit
2024
2023
Operating profit for the year is stated after charging:
£
£
Fees payable to the company's auditor for the audit of the company's financial statements
11,000
11,000
Depreciation of owned tangible fixed assets
82,021
91,702
5
Employees
The average monthly number of persons (excluding directors) employed by the company during the year was:
2024
2023
Number
Number
Operational and managerial staff
76
68
Their aggregate remuneration comprised:
2024
2023
£
£
Wages and salaries
1,817,680
1,458,035
Social security costs
155,114
116,946
Pension costs
32,604
23,757
2,005,398
1,598,738
6
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
518,797
497,111
7
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
170,000
Deferred tax
Origination and reversal of timing differences
195,000
Total tax charge
170,000
195,000
- 16 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
7
Taxation
(Continued)
The actual charge for the year can be reconciled to the expected charge/(credit) for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
Profit/(loss) before taxation
734,788
(441,565)
Expected tax charge/(credit) based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.50%)
183,697
(103,768)
Tax effect of expenses that are not deductible in determining taxable profit
213
130
Group relief
118,261
Permanent capital allowances in excess of depreciation
(14,359)
(14,520)
Other non-reversing timing differences
449
(103)
Deferred tax adjustments in respect of prior years
195,000
Taxation charge for the year
170,000
195,000
In addition to the amount charged to the profit and loss account, the following amounts relating to tax have been recognised directly in other comprehensive income:
2024
2023
£
£
Deferred tax arising on:
Revaluation of property
-
1,116,000
8
Tangible fixed assets
Freehold buildings
Plant and machinery
Fixtures, fittings & equipment
Total
£
£
£
£
Cost or valuation
At 1 January 2024
16,800,431
33,058
683,678
17,517,167
Additions
19,671
10,056
29,727
At 31 December 2024
16,800,431
52,729
693,734
17,546,894
Depreciation and impairment
At 1 January 2024
23,882
193,285
217,167
Depreciation charged in the year
13,691
68,330
82,021
At 31 December 2024
37,573
261,615
299,188
Carrying amount
At 31 December 2024
16,800,431
15,156
432,119
17,247,706
At 31 December 2023
16,800,431
9,176
490,393
17,300,000
- 17 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
8
Tangible fixed assets
(Continued)
The land and buildings have been valued on an open value basis at 31 December 2024 by the directors but with reference to independent professional valuations undertaken in connection with the company's financing facilities.
If revalued assets were stated on an historical cost basis rather than a fair value basis, the total amounts included would have been as follows:
2024
2023
£
£
Cost
10,059,050
10,059,050
Accumulated depreciation
(92,511)
(92,511)
Carrying value
9,966,539
9,966,539
9
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
71,021
73,376
Amounts owed by group undertakings
2,943,981
2,940,515
Other debtors
3,739
6,887
Prepayments and accrued income
93,907
86,435
3,112,648
3,107,213
10
Creditors: amounts falling due within one year
2024
2023
Notes
£
£
Bank loans
12
6,796,500
7,276,251
Obligations under finance leases
3,803
6,768
Trade creditors
648,437
373,719
Amounts owed to group undertakings
4,426,141
5,028,168
Corporation tax
170,017
17
Other taxation and social security
35,389
33,726
Other creditors
2,188
9,499
Accruals and deferred income
121,482
98,938
12,203,957
12,827,086
- 18 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
11
Creditors: amounts falling due after more than one year
2024
2023
Notes
£
£
Obligations under finance leases
4,427
12
Loans and overdrafts
2024
2023
£
£
Bank loans
6,796,500
7,276,251
Payable within one year
6,796,500
7,276,251
The bank loan from Coutts & Co. is secured by a fixed and floating charge over the assets of the company including its freehold land and property. Interest is payable on the loan at a rate of 2.5% per annum above SONIA.
The loan is repayable by quarterly instalments with a final balloon payment due to be repaid by 3 June 2024. However, at the time of approving these accounts, the company was still in the process of re-negotiating its bank finance arrangements. In the interim, the company has continued to make quarterly repayments totalling £394,000 in line with the original repayment schedule.
13
Deferred taxation
The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:
Liabilities
Liabilities
2024
2023
Balances:
£
£
Accelerated capital allowances
494,000
494,000
Revaluations
1,643,000
1,643,000
2,137,000
2,137,000
There were no deferred tax movements in the year.
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so.
The expected net reversal of deferred tax assets and liabilities in 2025 cannot be reliably estimated.
There is no expiry date on timing differences.
- 19 -
WESTGATE HEALTHCARE (WANSTEAD) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
14
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
32,604
23,757
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
15
Share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
2
2
2
2
16
Revaluation reserve
2024
2023
£
£
At the beginning of the year
5,190,892
1,935,122
Revaluation surplus arising in the year
4,371,770
Deferred tax on revaluation of tangible assets
-
(1,116,000)
At the end of the year
5,190,892
5,190,892
17
Related party transactions
The company has taken advantage of the exemption in FRS 102 Section 33 - Related Party Disclosures, from the requirement to disclose transactions with wholly owned group companies.true
18
Ultimate controlling party
The parent company is Westgate Healthcare Group Limited ('WHGL'), a company registered in England and Wales.
The directors have determined that there is no ultimate controlling party.
Consolidated financial statements are prepared by WHGL, copies of which are available from its registered office: Unit 3 Devonshire Business Park, Chester Road, Borehamwood, Hertfordshire, WD6 1NA.
- 20 -
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.100P. S. PatelA. P. PatelS. C. PatelS. P. FoxonT. D. Teubner082649542024-01-012024-12-3108264954bus:Director12024-01-012024-12-3108264954bus:Director22024-01-012024-12-3108264954bus:Director32024-01-012024-12-3108264954bus:Director42024-01-012024-12-3108264954bus:Director52024-01-012024-12-3108264954bus:RegisteredOffice2024-01-012024-12-31082649542023-01-012023-12-3108264954dpl:Item12024-01-012024-12-3108264954dpl:Item12023-01-012023-12-31082649542024-12-3108264954core:RetainedEarningsAccumulatedLosses2023-01-012023-12-3108264954core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3108264954core:RevaluationReserve2024-01-012024-12-3108264954core:RevaluationReserve2023-01-012023-12-3108264954core:RevenueReservesInvestmentFundsOnly2023-01-012023-12-31082649542023-12-3108264954core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3108264954core:PlantMachinery2024-12-3108264954core:FurnitureFittings2024-12-3108264954core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3108264954core:PlantMachinery2023-12-3108264954core:FurnitureFittings2023-12-3108264954core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3108264954core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3108264954core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3108264954core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3108264954core:CurrentFinancialInstruments2024-12-3108264954core:CurrentFinancialInstruments2023-12-3108264954core:ShareCapital2024-12-3108264954core:ShareCapital2023-12-3108264954core:RevaluationReserve2024-12-3108264954core:RevaluationReserve2023-12-3108264954core:RetainedEarningsAccumulatedLosses2024-12-3108264954core:RetainedEarningsAccumulatedLosses2023-12-3108264954core:ShareCapital2022-12-3108264954core:RevaluationReserve2022-12-3108264954core:RetainedEarningsAccumulatedLosses2022-12-31082649542022-12-3108264954core:ShareCapitalOrdinaryShareClass12024-12-3108264954core:ShareCapitalOrdinaryShareClass12023-12-3108264954core:RevaluationReserve2023-12-3108264954core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3108264954core:PlantMachinery2024-01-012024-12-3108264954core:FurnitureFittings2024-01-012024-12-3108264954core:UKTax2024-01-012024-12-3108264954core:UKTax2023-01-012023-12-3108264954core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3108264954core:PlantMachinery2023-12-3108264954core:FurnitureFittings2023-12-31082649542023-12-3108264954core:Non-currentFinancialInstruments2024-12-3108264954core:Non-currentFinancialInstruments2023-12-3108264954bus:OrdinaryShareClass12024-01-012024-12-3108264954bus:OrdinaryShareClass12024-12-3108264954bus:OrdinaryShareClass12023-12-3108264954bus:PrivateLimitedCompanyLtd2024-01-012024-12-3108264954bus:FRS1022024-01-012024-12-3108264954bus:Audited2024-01-012024-12-3108264954bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP